fluconazole has been researched along with cancidas in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 23 (63.89) | 29.6817 |
2010's | 12 (33.33) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB | 1 |
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
Chaffin, WL; Mekala, S; Perumal, P | 1 |
Calderone, R; Chauhan, N; Kruppa, M | 1 |
Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
Gesztelyi, R; Kardos, G; Kelentey, B; Majoros, L; Sóczó, G; Varga, I | 1 |
Barchiesi, F; Maida, CM; Milici, ME; Scalise, G; Spreghini, E | 1 |
Couet, W; Grégoire, N; Marliat, M; Venisse, N | 1 |
Albert, ND; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
Meletiadis, J; Papaioannidou, P; Roilides, E; Sein, T; Stergiopoulou, T; Tsiouris, I; Walsh, TJ | 1 |
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS | 1 |
Barchiesi, F; Giannini, D; Maida, CM; Milici, ME; Orlando, F; Scalise, G; Spreghini, E; Tomassetti, S | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Agarwal, AK; Ashfaq, MK; Babu, KS; Clark, AM; Elsohly, HN; Jacob, MR; Khan, SI; Li, XC; Manly, SP | 1 |
Chu, CC; Hsueh, PR; Ruan, SY | 1 |
Coleman, DC; Dudley, E; Kelly, DE; Kelly, SL; Lamb, DC; Melo, NR; Moran, GP; Smith, SN; Sullivan, DJ; Warrilow, AG | 1 |
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
Boikov, D; Nagappan, V; Vazquez, JA | 1 |
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G | 1 |
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
Akalin, G; Bertout, S; Demirci, F; Fulcrand, P; Maillard, LT; Martinez, J; Masurier, N; Quinonéro, O; Turan-Zitouni, G | 1 |
Abruzzo, G; Card, D; Chen, T; Dreikorn, S; Flattery, A; Gill, C; Hornak, V; Kelly, R; Kurtz, M; Li, X; Liu, W; Meinz, M; Onishi, JC; Rosenbach, M; Shafiee, A; Singh, SB; Thompson, JR | 1 |
Azzollini, A; Christen, P; Cretton, S; Cuendet, M; Dorsaz, S; Ebrahimi, SN; Favre-Godal, Q; Gindro, K; Marcourt, L; Michellod, E; Sanglard, D; Voinesco, F; Wolfender, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
Garneau-Tsodikova, S; Howard, KC; Ngo, HX; Shrestha, SK; Thamban Chandrika, N; Tsodikov, OV | 1 |
Garneau-Tsodikova, S; Howard, KC; Ngo, HX; Shrestha, SK; Thamban Chandrika, N | 1 |
Masoodi, KZ; Padder, SA; Prasad, R; Ramzan, A; Rehman, RU; Shafi, S; Shah, AH; Tahir, I | 1 |
1 review(s) available for fluconazole and cancidas
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
35 other study(ies) available for fluconazole and cancidas
Article | Year |
---|---|
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests | 2007 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
In vitro study of Candida tropicalis isolates exhibiting paradoxical growth in the presence of high concentrations of caspofungin.
Topics: Antifungal Agents; Candida tropicalis; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Time Factors | 2007 |
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Administration Schedule; Echinocandins; Humans; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Models, Biological | 2008 |
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
Topics: Antifungal Agents; Drug Resistance, Fungal; Gene Deletion; Gene Library; Genome, Fungal; Gliotoxin; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Humans; Microbial Sensitivity Tests; Regression Analysis | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation | 2008 |
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Topics: Animals; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Kidney; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Potent in vitro antifungal activities of naturally occurring acetylenic acids.
Topics: Alkynes; Animals; Antifungal Agents; Candida albicans; Cell Line; Fatty Acids, Unsaturated; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Rubiaceae; Trichophyton | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility.
Topics: Base Sequence; Candida albicans; Cell Wall; Cytochrome P-450 Enzyme System; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Gene Deletion; Gene Expression; Genes, Fungal; Mutation; Phenotype; Recombinant Proteins; Tyrosine | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives.
Topics: Animals; Antifungal Agents; Candida; Candida albicans; Cell Survival; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Structure-Activity Relationship; Thiazoles | 2013 |
Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h.
Topics: | 2012 |
Antifungal Quinoline Alkaloids from Waltheria indica.
Topics: Alkaloids; Antifungal Agents; Candida albicans; Flavonoids; Humans; Malvaceae; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Structure; Niger; Nuclear Magnetic Resonance, Biomolecular; Plant Components, Aerial; Plant Roots; Quinolines | 2016 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.
Topics: 14-alpha Demethylase Inhibitors; Alkylation; Animals; Antifungal Agents; Aspergillus; Azoles; Candida albicans; Cell Line; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Protein Conformation; Sterol 14-Demethylase | 2018 |
Novel fluconazole derivatives with promising antifungal activity.
Topics: Animals; Antifungal Agents; Candida; Cell Line; Cell Survival; Drug Design; Erythrocytes; Fluconazole; Fungi; Hemolysis; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Voriconazole | 2018 |
β-Nitrostyrene derivatives as broad range potential antifungal agents targeting fungal cell wall.
Topics: Antifungal Agents; Candida albicans; Cell Wall; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Styrenes | 2022 |